My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 201

    1.

    Should we be more aggressive in the therapy against cardiovascular risk factors? Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?

    Stirban AO, Tschoepe D.

    Diabetes Care. 2008 Feb;31 Suppl 2:S226-8.PMID: 18227490 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?

    Wienbergen H, Senges J, Gitt AK.

    Diabetes Care. 2008 Feb;31 Suppl 2:S222-5. No abstract available. PMID: 18227489 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    [The Polypill: between myths and reality in the treatment of type 2 diabetes mellitus]

    Ruiz J, Egli M.

    Rev Med Suisse. 2006 May 31;2(68):1480-2, 1484-5. Review. French. PMID: 16783994 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Factors that influence the implementation of the guidelines for aspirin use by diabetic patients in Israel]

    Azuz N, Thomas K, Yaffe Y, Katz M, Weingarten M, Matalon A.

    Harefuah. 2008 Dec;147(12):971-4, 1030. Hebrew. PMID: 19260592 [PubMed - indexed for MEDLINE]Related articles

    5.

    Do people with diabetes need statins?

    White JR Jr.

    Diabetes Educ. 2008 Jul-Aug;34(4):664-73.PMID: 18669808 [PubMed - indexed for MEDLINE]Related articles

    6.

    Statins for primary prevention in type 2 diabetes.

    [No authors listed]

    Drug Ther Bull. 2006 Aug;44(8):57-60. Review.PMID: 16903486 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?

    Moyad MA, Merrick GS.

    Urol Nurs. 2007 Apr;27(2):166-8.PMID: 17494461 [PubMed - indexed for MEDLINE]Related articles

    8.

    Multi-constituent cardiovascular pills (MCCP)--challenges and promises of population-based prophylactic drug therapy for prevention of heart attack.

    Jamieson MJ, Naghavi M.

    Curr Pharm Des. 2007;13(10):1069-76. Review.PMID: 17430169 [PubMed - indexed for MEDLINE]Related articles

    9.

    Initiating statins in the elderly: the evolving challenge.

    Walker DB, Jacobson TA.

    Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):182-7. Review.PMID: 18316955 [PubMed - indexed for MEDLINE]Related articles

    10.

    Lower is better--the contemporary concept of low-density lipoprotein lowering in the preventive management of cardiovascular risk: does this apply to all patients?

    Nixon JV.

    Prev Cardiol. 2006 Fall;9(4):219-25; quiz 226-7. Review.PMID: 17085985 [PubMed - indexed for MEDLINE]Related articles

    11.

    Statin utilization patterns for the primary prevention of cardiovascular events: a retrospective study in patients with diabetes mellitus in Hong Kong.

    Lee VW, Ho IC, Chan WS, Tam KY, Lee KK.

    Am J Cardiovasc Drugs. 2008;8(3):199-205.PMID: 18533740 [PubMed - indexed for MEDLINE]Related articles

    12.

    Statins and CVD prevention in the diabetic population: implications of the CARDS trial.

    Murad O, Palmer J, Sowers J, McFarlane SI.

    Curr Diab Rep. 2005 Jun;5(3):191-3. Review. No abstract available. PMID: 15929865 [PubMed - indexed for MEDLINE]Related articles

    13.

    Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy.

    Poluzzi E, Strahinja P, Lanzoni M, Vargiu A, Silvani MC, Motola D, Gaddi A, Vaccheri A, Montanaro N.

    Eur J Clin Pharmacol. 2008 Apr;64(4):425-32. Epub 2008 Jan 5.PMID: 18176802 [PubMed - indexed for MEDLINE]Related articles

    14.

    Statin therapy in people with diabetes and high-risk patients.

    Wierzbicki AS.

    Hosp Med. 2003 Jan;64(1):16-9. Review.PMID: 12572329 [PubMed - indexed for MEDLINE]Related articles

    15.

    Antiplatelet therapy for primary prevention in diabetes.

    Ambrosi P, Villani P, Bouvenot G.

    Diabetes Metab. 2006 Sep;32 Spec No2:2S52-6. Review.PMID: 17375409 [PubMed - indexed for MEDLINE]Related articles

    16.

    Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

    Hausenloy DJ, Yellon DM.

    Heart. 2008 Jun;94(6):706-14. Review.PMID: 18480348 [PubMed - indexed for MEDLINE]Related articles

    17.

    Preventing macrovascular complications in type 2 diabetes mellitus: glucose control and beyond.

    Stancoven A, McGuire DK.

    Am J Cardiol. 2007 Jun 4;99(11A):5H-11H. Review.PMID: 17665747 [PubMed - indexed for MEDLINE]Related articles

    18.

    Prospects and possible pitfalls of a preventive Polypill: confessions of a health promotion convert.

    Green LW.

    Eur J Clin Nutr. 2005 Aug;59 Suppl 1:S4-8; discussion S9.PMID: 16052194 [PubMed - indexed for MEDLINE]Related articles

    19.

    Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia.

    Ali YS, Linton MF, Fazio S.

    Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):142-6. Review.PMID: 18316949 [PubMed - indexed for MEDLINE]Related articles

    20.

    Is it time for a cardiovascular primary prevention trial in the elderly?

    Robinson JG, Bakris G, Torner J, Stone NJ, Wallace R.

    Stroke. 2007 Feb;38(2):441-50. Epub 2006 Dec 28. Review.PMID: 17194877 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity